Overcoming immunological tolerance is a way of treating malignant tumors: new perspectives

This literature review outlines the current knowledge of the mechanisms of antitumor immunity and the role of one of the new classes of immunomodulators blocking immune regulatory molecules CTLA4, which soon could be used by oncology practitioners in Russia and has already been successfully used for...

Full description

Bibliographic Details
Main Authors: I V Samoilenko, G U Kharkevich, L V Demidov
Format: Article
Language:Russian
Published: IP Habib O.N. 2014-03-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/view/26938